Key points:
1. Abridge closed a $300 million Series E and launched an inpatient module integrated with Epic that speeds up note completion and reduces after-hours charting.
2. The company’s ambient AI tools are expanding rapidly, with projections for 50 million encounters this year and international expansion plans underway.
Pittsburgh start-up Abridge closed a $300 million Series E on June 24 that doubled its valuation to $5.3 billion. The funding coincided with Abridge Inside for Inpatient, an Epic-integrated module that converts bedside talk to structured notes. Sutter Health pilots show progress-note closure in under two minutes, according to the launch release. A pediatric template has earned an average 4.5-star rating across 25 000 encounters, feedback summarized in an Abridge blog. Digital Health Wire reports the platform now supports 150-plus enterprise systems and is on pace for 50 million encounters this year. The inpatient build emerged from Epic’s Workshop track, a co-development route Business Wire says cuts security review cycles by 60 percent. CEO Shiv Rao told MedCity News that a revenue-cycle copilot, now training on 12 million labeled claims, hits 98 percent first-pass acceptance in payer pilots. A HFMA session projected that even a one-point coding lift could yield hospitals $700 million over three years. Nemours Children’s reported a 32 percent drop in after-hours charting during a six-week evaluation, results shared in a JAMA Network Open preprint. User sentiment measured by KLAS Research shows a four-point net-promoter gain among Abridge adopters. Rao plans specialty templates for neonatology and oncology by Q4, expanding the addressable market 40 percent. Foley & Lardner’s health-tech brief ranks the round as the second-largest digital-scribe deal ever. International expansion talks are under way in the U.K. and Australia, where Epic penetration is rising. Ambient AI appears to be pivoting from novelty to necessity for documentation-burdened clinicians.
Image: PD
©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.